Last update 02 Aug 2025

Ketorolac

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ketorolac (INN), Ketorolac (PMB), Ketorolac (PMC)
+ [9]
Action
inhibitors
Mechanism
COX-1 inhibitors(Cyclooxygenase-1 inhibitors), COX-2 inhibitors(Cyclooxygenase-2 inhibitors)
Inactive Indication-
Originator Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC15H13NO3
InChIKeyOZWKMVRBQXNZKK-UHFFFAOYSA-N
CAS Registry74103-06-3

External Link

KEGGWikiATCDrug Bank
D08104Ketorolac

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pain, PostoperativePhase 3--
Post procedural inflammationPhase 1
United States
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
tcywbfzpic(asypifnntc) = ithhwkjvjp bueavkaofw (mwxfwcdqgp )
Positive
05 Nov 2024
-
Phase 1/2
17
Normal Saline, Prochlorperazine, Ketorolac
filpezxvlr(pyfilaoxym) = cxgbcyfvis scggynmaot (sxosdtzrqz )
Positive
01 Oct 2023
Not Applicable
-
Opioid medications
iitrzbtfin(pgzqweauln) = hwnrpyqtkx wnvocpydhh (nsayjerjbi )
-
09 May 2023
Non-opioid analgesics
iitrzbtfin(pgzqweauln) = gneulfvxjv wnvocpydhh (nsayjerjbi )
Phase 3
60
Lidocaine+Adrenaline+Ketorolac
dnqmsiuuxi(mhksqawzye) = cccundqtbl yjednrffwd (dzryoqneyx, 2.0)
Negative
01 Sep 2022
Lidocaine+Adrenaline+Triamcinolone Acetonide
dnqmsiuuxi(mhksqawzye) = izmucthnmb yjednrffwd (dzryoqneyx, 3.2)
Phase 2/3
50
(Paracervical Block With Lidocaine)
mxesqugmwv(mrnhgylpcj) = gjbsgatbex yvwaqjupuq (uotcmzqeaa, 20.8)
-
15 Sep 2014
(Paracervical Block With Ketorolac and Lidocaine)
mxesqugmwv(mrnhgylpcj) = msdkpmgjtt yvwaqjupuq (uotcmzqeaa, 25.4)
Not Applicable
11
aikrveqfdj(vrfkhtndwo) = hoxjrotebu wzxhxnhhwt (locdemmziu, 2.2)
-
29 Apr 2014
Phase 2/3
50
eyuphllefk(ciplwbmauv) = pbpmfjiclf jcofhurbkh (keuujyvkps )
-
01 Dec 2009
Oral placebo + Combined ketorolac and lidocaine paracervical block
eyuphllefk(ciplwbmauv) = ukiapwgzey jcofhurbkh (keuujyvkps )
Phase 2
-
23
Cyclosporine A monotherapy
ruwangmgob(bzlzonhjca) = scbupdtsqi ydruwuqebw (kzhwqwjbtj )
Positive
01 May 2005
Ketorolac followed by cyclosporine A instillation
ruwangmgob(bzlzonhjca) = pwrmegvipi ydruwuqebw (kzhwqwjbtj )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free